(FBIO) Fortress Biotech - Performance -0.6% in 12m
Compare FBIO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-85.51%
#150 in Group
Rel. Strength
43.68%
#4482 in Universe
Total Return 12m
-0.59%
#49 in Group
Total Return 5y
-95.73%
#135 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -0.10
50th Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: FBIO (-0.6%) vs XBI (-14.9%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: FBIO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for FBIO
Total Return (including Dividends) | FBIO | XBI | S&P 500 |
---|---|---|---|
1 Month | 15.75% | 2.77% | 5.69% |
3 Months | -1.17% | -14.21% | -6.49% |
12 Months | -0.59% | -14.88% | 9.72% |
5 Years | -95.73% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | FBIO | XBI | S&P 500 |
1 Month | 83.8% | 57% | 89.4% |
3 Months | -1.90% | -82.3% | -72% |
12 Months | -38.6% | -53.1% | 49.3% |
5 Years | -94.0% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #63 | 12.6% | 9.52% |
3 Month | #53 | 15.2% | 5.69% |
12 Month | #50 | 16.8% | -9.39% |
5 Years | #142 | -94.2% | -97.9% |
FAQs
Does FBIO Fortress Biotech outperforms the market?
Yes,
over the last 12 months FBIO made -0.59%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months FBIO made -1.17%, while XBI made -14.21%.
Over the last 3 months FBIO made -1.17%, while XBI made -14.21%.
Performance Comparison FBIO vs Indeces and Sectors
FBIO vs. Indices FBIO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -5.21% | 10.1% | 1.17% | -10.3% |
US NASDAQ 100 | QQQ | -5.48% | 8.36% | 0.76% | -11.4% |
US Dow Jones Industrial 30 | DIA | -5.10% | 13.1% | 2.20% | -6.84% |
German DAX 40 | DAX | -5.66% | 0.69% | -24.4% | -25.4% |
Shanghai Shenzhen CSI 300 | CSI 300 | -5.44% | 12.9% | 1.94% | -6.90% |
Hongkong Hang Seng | HSI | -8.09% | 0.85% | -8.32% | -8.81% |
India NIFTY 50 | INDA | -1.51% | 12.5% | -0.73% | -2.62% |
Brasil Bovespa | EWZ | -8.24% | 4.13% | -8.04% | 5.68% |
FBIO vs. Sectors FBIO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -4.58% | 9.27% | -5.01% | -21.0% |
Consumer Discretionary | XLY | -6.63% | 9.06% | 3.36% | -15.4% |
Consumer Staples | XLP | -4.35% | 15.1% | -5.74% | -7.84% |
Energy | XLE | -7.46% | 11.3% | 7.17% | 8.43% |
Financial | XLF | -5.91% | 8.91% | -4.71% | -22.1% |
Health Care | XLV | -1.11% | 18.8% | 6.40% | 5.42% |
Industrial | XLI | -6.14% | 7.44% | 0.19% | -11.0% |
Materials | XLB | -5.37% | 10.7% | 5.22% | 5.49% |
Real Estate | XLRE | -4.42% | 8.84% | -1.21% | -14.2% |
Technology | XLK | -6.05% | 6.04% | 3.44% | -6.69% |
Utilities | XLU | -5.93% | 10.6% | -6.60% | -16.6% |
Aerospace & Defense | XAR | -5.39% | 6.58% | -8.13% | -26.6% |
Biotech | XBI | 2.51% | 13.0% | 22.2% | 14.3% |
Homebuilder | XHB | -4.85% | 10.1% | 14.8% | 8.28% |
Retail | XRT | -5.27% | 9.61% | 7.46% | 5.67% |